Dear Colleague
As you may be aware, SPPG issued correspondence on Monday 23 January to those pharmacies providing the Regional Stop Smoking Service.

SUMMARY

The letter includes important updates in relation to:

  • The rolling forward of the “Stop Smoking” service contract
  • Information on replacing Carbon Monoxide monitors used to provide the service

ACTION

Contractors are asked to note:

  • The contents of the letter and bring it to the attention of relevant staff

For queries in relation to the service please contact your PHA local Tobacco coordinator.  Queries may also be directed to a member of the CPNI team.

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS

CPNI ALERTS

DOH(NI) ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
The second update of concessionary prices were granted today for January 2023:
DrugPack SizeConcessionary Price
Carbocisteine 250mg/5ml oral solution300£8.50
Cinnarizine 15mg tablets84£7.51
Clarithromycin 500mg tablets14£10.48
Co-amoxiclav 250mg/125mg tablets21£3.54
Colecalciferol 1,000unit capsules30£8.40
Erythromycin 250mg gastro-resistant tablets28£2.52
Flucloxacillin 250mg capsules28£2.98
Flucloxacillin 500mg capsules28£4.48
Frovatriptan 2.5mg tablets6£15.05
Fusidic acid 1% modified-release eye drops5£26.63
Gabapentin 600mg tablets100£25.00
Hydroxocobalamin 1mg/1ml solution for
injection ampoules
5£13.19
Levetiracetam 1g tablets60£7.62
Methylphenidate 10mg tablets30£3.55
Omeprazole 10mg gastro-resistant capsules28£1.35
Paracetamol 500mg soluble tablets24£3.66
Paracetamol 500mg soluble tablets100£15.25
Pregabalin 150mg capsules56£2.42
Pregabalin 75mg capsules56£2.30
Promethazine hydrochloride 25mg tablets56£34.19
Topiramate 50mg tablets60£19.85
Trazodone 100mg capsules56£5.99
Trazodone 50mg capsules84£7.56
Venlafaxine 75mg tablets56£14.21
Zolmitriptan 2.5mg orodispersible tablets
sugar free
6£8.76
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE

Chief Executive
Dear Colleague
The first update of concessionary prices were granted today for January 2023:
DrugPack SizeConcessionary Price
Amisulpride 100mg tablets60£20.29
Amisulpride 200mg tablets60£33.92
Amisulpride 50mg tablets60£13.09
Amoxicillin 125mg/5ml oral suspension sugar free100£3.70
Amoxicillin 250mg/5ml oral suspension100£4.34
Amoxicillin 500mg capsules15£3.02
Amoxicillin 500mg capsules21£4.23
Aripiprazole 15mg tablets28£25.24
Atenolol 25mg tablets28£1.46
Bicalutamide 150mg tablets28£4.09
Bimatoprost 100micrograms/ml eye drops3£3.96
Bisacodyl 5mg gastro-resistant tablets60£4.99
Bisoprolol 2.5mg tablets28£1.02
Carbocisteine 375mg capsules120£14.75
Carvedilol 6.25mg tablets28£1.02
Celecoxib 100mg capsules60£6.26
Chloramphenicol 1% eye ointment4£4.30
Chlorpromazine 100mg tablets28£28.50
Chlorpromazine 25mg tablets28£28.97
Chlorpromazine 50mg tablets28£28.99
Cinacalcet 30mg tablets28£13.55
Citalopram 40mg/ml oral drops sugar free15£9.99
Clarithromycin 125mg/5ml oral suspension70£4.93
Clindamycin 150mg capsules24£3.00
Clotrimazole 1% cream20£2.22
Clotrimazole 1% cream50£5.55
Clotrimazole 500mg pessaries1£10.35
Co-amilofruse 2.5mg/20mg tablets28£4.32
Co-codamol 30mg/500mg effervescent tablets32£3.52
Co-codamol 30mg/500mg effervescent tablets100£10.99
Cyclizine 50mg/1ml solution for injection ampoules5£13.90
Desogestrel 75microgram tablets84£4.01
Digoxin 125microgram tablets28£4.75
Digoxin 250microgram tablets28£4.86
Digoxin 62.5microgram tablets28£4.83
Donepezil 10mg tablets28£1.28
Donepezil 5mg tablets28£1.30
Dosulepin 25mg capsules28£6.44
Duloxetine 30mg gastro-resistant capsules28£3.68
Escitalopram 10mg tablets28£1.70
Finasteride 5mg tablets28£4.99
Ivabradine 5mg tablets56£9.70
Lamotrigine 100mg tablets56£2.63
Lamotrigine 25mg dispersible tablets sugar free56£8.72
Lamotrigine 50mg tablets56£2.39
Latanoprost 50micrograms/ml eye drops2.5£2.25
Levetiracetam 100mg/ml oral solution sugar free300£14.42
Levetiracetam 500mg tablets60£4.19
Mebeverine 135mg tablets100£6.39
Methocarbamol 750mg tablets100£12.93
Metoprolol 50mg tablets28£1.95
Mometasone 50micrograms/dose nasal spray140£4.25
Mycophenolate mofetil 500mg tablets50£8.61
Naproxen 250mg gastro-resistant tablets56£2.76
Naproxen 500mg gastro-resistant tablets56£5.57
Naproxen 500mg tablets28£1.89
Nebivolol 2.5mg tablets28£18.20
Nebivolol 5mg tablets28£1.76
Nitrofurantoin 100mg tablets28£15.65
Norethisterone 5mg tablets30£7.39
Paroxetine 20mg tablets30£1.71
Phenoxymethylpenicillin 250mg tablets28£3.99
Prednisolone 5mg soluble tablets30£60.83
Pregabalin 100mg capsules84£3.70
Pregabalin 25mg capsules56£1.83
Pregabalin 300mg capsules56£4.11
Pregabalin 50mg capsules84£2.63
Quetiapine 300mg tablets60£4.47
Quinine sulfate 200mg tablets28£4.89
Rasagiline 1mg tablets28£4.68
Risedronate sodium 35mg tablets4£3.02
Rivastigmine 3mg capsules28£5.49
Tamsulosin 400microgram / Dutasteride 500microgram
capsules
30£19.80
Telmisartan 20mg tablets28£5.59
Telmisartan 80mg tablets28£4.12
Temazepam 10mg tablets28£28.79
Topiramate 25mg tablets60£12.00
Tranexamic acid 500mg tablets60£6.92
Trospium chloride 20mg tablets60£14.40
Valsartan 160mg capsules28£8.99
`Valsartan 40mg capsules28£6.82
Zopiclone 3.75mg tablets28£1.27
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
NICPLD and the Head of the Medicines Regulatory Group (MRG) have written to pharmacists giving details of a series of FMD workshops to be held in February and March 2023. These letters are available HERE (NICPLD) and HERE (MRG).

These training events are aimed at improving knowledge and understanding of the pharmacists’ role in the implementation of the Falsified Medicines Directive (FMD).  The events will be hosted by representatives from MRG, SecurMed and a software provider who will give an overview of the legislation, common error messages and a practical demonstration of the system.

Details of the training events can be found HERE.

It has been confirmed that NICPLD/MRG are happy to accommodate attendance of one member of pharmacy staff alongside a pharmacist at these workshops. Those wishing to avail of this opportunity, should contact NICPLD directly via email at nicpld@qub.ac.uk

ACTION

Contractors are asked to note:

  • The contents of the letters and bring it them to the attention of relevant staff.

All queries should be directed to NICPLD in the first instance.

Kind regards – Mike

SENT ON BEHALF OF
PROF. MIKE MAWHINNEY
Head of Regulatory Affairs

Dear Contractor,
 
Contractors were notified on 1 December 2022 of correspondence received from the Pharmaceutical Society NI (PSNI) on 30 November 2022 in respect of changes to the responsibilities of Responsible and Superintendent Pharmacists, some of which came into effect on 1 December 2022.

ACTION

Contractors are advised to:

  • Read the attached correspondence, note the changes coming in with immediate effect and take any appropriate action.
  • Should contractors have queries on these changes which they would like to be addressed in the FAQ document referred to in the Registrar’s letter, please email these to Mike and Ennis so that they can be collated and forwarded to PSNI.

Any immediate queries on these changes should be raised directly with the Registrar, PSNI via the contact information given in the attachment.

Please do not hesitate to contact the CPNI office should you require further information.

Kind regards

SENT ON BEHALF OF 
GERARD GREENE
Chief Executive